Paul R. Gugliuzza in the Media

Law.com September 28, 2026

Short Shrift? Supreme Court Clerk Hiring Mostly Skips This Appeals Court

Professor Paul Gugliuzza recognizes how, in terms of hiring Supreme Court clerks, perceptions differ regarding clerks at the Federal Circuit and those at the D.C. Circuit, despite both having outstanding credentials.

PatentlyO September 22, 2026

The Federal Circuit Expands Its Jurisdiction Yet Again

Professor Paul Gugliuzza authors a guest post arguing the Federal Circuit wrongfully answered the jurisdictional question in Insulet v. EOFlow by holding the trade secret case arose under patent law.

Bloomberg Law September 2, 2026

A&O Shearman Brings on Patent Judge Alan Albright: Texas Brief

Professor Paul Gugliuzza shares why he believes Judge Alan Albright will have a positive impact on A&O Shearman's Austin office.

Daily Journal August 21, 2026

East Texas reclaims its patent crown

Professor Paul Gugliuzza says the Eastern District of Texas remains attractive to patent plaintiffs because of its experienced judges, fast schedules and trial-focused procedures, while defendants—particularly tech companies—have struggled to transfer cases out of the district.

Law360 August 17, 2026

Medtech Group Faults Fed. Circ. Trade Secret Timing Rule

An amicus brief filed by Professor Paul Gugliuzza urging the full Federal Circuit to revisit a decision that wiped out Insulet Corporation's trade secret win against EOFlow Co. Ltd. is highlighted.

Yale Journal on Regulation August 10, 2026

Law, Discretion, and Psychedelics

Professor Paul Gugliuzza applies Judge Henry Friendly's landmark lecture on legal discretion to the Ninth Circuit's AIMS decision, examining how the DEA's broad authority can both block and accelerate patient access to investigational psychedelic therapies.

Bloomberg Law July 22, 2026

A Cycling Icon Took on a Prolific Lawyer. The Dude Got Personal

In an article about a lawsuit against  a company owned by former cyclist Floyd Landis, Professor Paul Gugliuzza discusses the high-volume patent litigation model, noting that the potential profitability from a large number of small settlements.

Health Affairs July 9, 2026

The Supreme Court Protected Generics. Now FDA Must Navigate The Aftermath

Professor Paul Gugliuzza examines how the Supreme Court's Hikima decision protects generic drug manufactures and argues the FDA should clarify its "skinny-label" approval process to reduce patent disputes and preserve access to affordable medicines.

Law360 June 15, 2026

Newman’s Appeal Loss Shows Limits On Suspension Reviews

Professor Paul Gugliuzza analyzes aspects of a long-running dispute over a federal circuit judge's suspension and subsequent appeal.

Law.com June 8, 2026

Atlanta Civil Rights Attorney Cleared of Criminal Indictment Connected to Judge Shopping Investigation

Professor Paul Gugliuzza comments on the dismissal of a criminal indictment connected to an Alabama judge shopping investigation, noting reasons that the case appeared weak.

Bloomberg News June 4, 2026

Micron Battle Reveals Need for Clear Patent Jurisdiction Rules

Professor Paul Gugliuzza contends that, as state “anti-troll” statutes become more commonly used in patent disputes, courts need a jurisdictional rule that is clear and respects the difference between federal patent cases and state-law cases that simply have patents in them.

The Texas Tribune May 21, 2026

Ken Paxton wanted to limit forum shopping. Now lawyers say he’s improperly seeking favorable courts.

Professor Paul R. Gugliuzza questions the legality of Attorney General Ken Paxton's pattern of filing lawsuits in counties with little connection to the alleged wrongdoing.